Nurix Therapeutics (NASDAQ:NRIX – Get Free Report)‘s stock had its “buy” rating restated by research analysts at Needham & Company LLC in a research report issued to clients and investors on Tuesday,Benzinga reports. They presently have a $34.00 price target on the stock. Needham & Company LLC’s target price would indicate a potential upside of […]

Research analysts at Bank of America assumed coverage on shares of ITG (NASDAQ:ITG – Get Free Report) in a research note issued on Monday. The firm set a “buy” rating and a $16.00 price target on the stock. Bank of America‘s price objective suggests a potential upside of 18.87% from the stock’s previous close. Several […]

Needham & Company LLC started coverage on shares of Immix Biopharma (NASDAQ:IMMX – Free Report) in a research note published on Wednesday, Marketbeat Ratings reports. The brokerage issued a buy rating and a $21.00 price target on the stock. A number of other equities research analysts have also recently weighed in on the company. Bank […]

Research analysts at Maxim Group began coverage on shares of Cyabra (NASDAQ:CYAB – Get Free Report) in a research report issued to clients and investors on Thursday. The brokerage set a “buy” rating and a $1.00 price target on the stock. Maxim Group’s target price would suggest a potential upside of 251.00% from the stock’s […]

Research analysts at Evercore assumed coverage on shares of Tenax Therapeutics (NASDAQ:TENX – Get Free Report) in a research note issued on Wednesday. The firm set an “outperform” rating and a $39.00 price target on the specialty pharmaceutical company’s stock. Evercore’s price target indicates a potential upside of 148.09% from the stock’s previous close. Several […]